BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32468556)

  • 1. Detecting Common Pathways and Key Molecules of Neurodegenerative Diseases from the Topology of Molecular Networks.
    Vrahatis AG; Kotsireas IS; Vlamos P
    Adv Exp Med Biol; 2020; 1194():409-421. PubMed ID: 32468556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative system-level analysis of the neurodegenerative diseases.
    Godini R; Fallahi H; Ebrahimie E
    J Cell Physiol; 2019 Apr; 234(4):5215-5229. PubMed ID: 30203456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network approach to clinical intervention in neurodegenerative diseases.
    Santiago JA; Potashkin JA
    Trends Mol Med; 2014 Dec; 20(12):694-703. PubMed ID: 25455073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal network disintegration: common pathways linking neurodegenerative diseases.
    Ahmed RM; Devenney EM; Irish M; Ittner A; Naismith S; Ittner LM; Rohrer JD; Halliday GM; Eisen A; Hodges JR; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1234-1241. PubMed ID: 27172939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview.
    Ahmad K; Baig MH; Mushtaq G; Kamal MA; Greig NH; Choi I
    Curr Alzheimer Res; 2017; 14(11):1190-1197. PubMed ID: 28164765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets.
    Wang JKT; Langfelder P; Horvath S; Palazzolo MJ
    Front Neurosci; 2017; 11():149. PubMed ID: 28611571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular neurodegeneration: basic biology and disease pathways.
    Vassar R; Zheng H
    Mol Neurodegener; 2014 Sep; 9():34. PubMed ID: 25248568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles in neurodegenerative diseases.
    Croese T; Furlan R
    Mol Aspects Med; 2018 Apr; 60():52-61. PubMed ID: 29137922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.
    Brennan S; Keon M; Liu B; Su Z; Saksena NK
    Mol Neurobiol; 2019 Nov; 56(11):7380-7407. PubMed ID: 31037649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes: From the Physiology to the Disease.
    Trujillo-Estrada L; Gomez-Arboledas A; Forner S; Martini AC; Gutierrez A; Baglietto-Vargas D; LaFerla FM
    Curr Alzheimer Res; 2019; 16(8):675-698. PubMed ID: 31470787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insight into neurodegeneration: the role of proteomics.
    Pal R; Alves G; Larsen JP; Møller SG
    Mol Neurobiol; 2014 Jun; 49(3):1181-99. PubMed ID: 24323427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.
    Nayak A; Salt G; Verma SK; Kishore U
    Int Rev Neurobiol; 2015; 121():59-86. PubMed ID: 26315762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Kori M; Aydın B; Unal S; Arga KY; Kazan D
    OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNAs in neurodegeneration induced by environmental neurotoxicants and aging.
    Singh T; Yadav S
    Ageing Res Rev; 2020 Jul; 60():101068. PubMed ID: 32283224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause.
    Cavaleri F
    Med Hypotheses; 2015 Dec; 85(6):779-90. PubMed ID: 26604027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.
    Vasconcelos CFM; Ribas VT; Petrs-Silva H
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
    Lee B; Shin M; Park Y; Won SY; Cho KS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.